Table 3.

Clinical Trials Involving Pterostilbene.

Clinical Trial	Subjects	The Drug Used/Diet	Status	Findings	Reference
Studying the Effects of ElevATP on Body Composition and Athletic Performance of Healthy Individuals	Healthy 18–35-year-old males	ElevATP with and without caffeine and Vitamins	Completed	Improved strength and power output in the lower body	ClinicalTrials.gov Identifier: NCT02819219
Study of Pharmacokinetics and Safety of Basis™ in Subjects with Acute Kidney Injury	Patients with Acute Kidney Injury	Basis	Completed	Nicotinamide riboside with pterostilbene increased whole-blood NAD + levels	ClinicalTrials.gov Identifier: NCT03176628
Effect of PTS on Cholesterol and Hypertension	Patients with hyperlipidemia and increased Blood Pressure	1. PTS (low dosage of 50 mg and high dosage of 125 mg) 2. Low dose combination of PTS and grape extract (50 mg + 100 mg)	Completed	PTS increased LDL and reduced blood pressure in adults [95]	ClinicalTrials.gov Identifier: NCT01267227
Evaluating Safety and Benefits of Basis™ Among Elderly Subjects	60–80-year-old healthy subjects	Basis™	Completed	Yet to be published	ClinicalTrials.gov Identifier: NCT02678611
A Trial of Nicotinamide/PTS Supplement in Amyotrophic Lateral Sclerosis	Patients with Amyotrophic Lateral Sclerosis	EH301 (nicotinamide riboside/PTS)	Recruiting	Yet to be published	ClinicalTrials.gov Identifier: NCT05095571
Effect of Blueberries in Postmenopausal Women with Elevated Blood Pressure for Improving Vascular Endothelial Function	Postmenopausal women with elevated blood pressure, hypertension, and endothelial dysfunction	Blueberry powder	Active Phase 2 Phase 3	Yet to be published	ClinicalTrials.gov Identifier: NCT03370991
Supplementing Wild Blueberries to Study Cardiovascular Health in Middle-aged/Older Men	45- to 70-year-old men with hypertension and endothelial dysfunction	Blueberry powder	Recruiting Phase 1 Phase 2	Yet to be published	ClinicalTrials.gov Identifier: NCT04530916
Effect of High-intensity Training and Daily Consumption of Basis™ on Muscle Metabolism and Exercise	18- to 25-year-old healthy men	NRPT (125 mg nicotinamide riboside and 25 mg PTS)	Phase 1	Yet to be published	ClinicalTrials.gov Identifier: NCT04050358
Study of Treating Megestrol Acetate with or without PTS in Patients with Endometrial Cancer Undergoing Hysterectomy	Women with Atypical Endometrial Hyperplasia and Endometrial Carcinoma	Megestrol Acetate with or without PTS	Recruiting Phase 2	Yet to be published	ClinicalTrials.gov Identifier: NCT03671811
Protection of Basis™ in Acute Kidney Injury	Patients with Acute Kidney Injury	Nicotinamide riboside + PTS	Recruiting Phase 2	Yet to be published	ClinicalTrials.gov Identifier: NCT04342975
Studying the Benefit of Supplementation with Short-term Curcumin and Multi-polyphenol	Non-smokers in good health not taking medications or dietary supplements	Polyresveratrol supplementation (100 mg of trans-PTS, 100 mg of curcumin phytosome, 100 mg of quercetin phytosome, 100 mg of green tea phytosome, and 100 mg of trans-resveratrol)	Unknown	Not Published	ClinicalTrials.gov Identifier: NCT02998918
Studying effects of Nicotinamide Riboside and PTS on Muscle Regeneration in Elderly Humans	55- to 80-year- old individuals	Nicotinamide riboside/PTS-NRPT (500 mg/100 mg twice daily)	Completed	Not published	ClinicalTrials.gov Identifier: NCT03754842
Evaluating Sirtuin Supplements to Benefit Elderly Trauma Patients to study recovery of function	Individuals 65 years and older presenting to trauma bay	Nicotinamide riboside and PTS	Unknown	Not published	ClinicalTrials.gov Identifier: NCT03635411
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndrome, Estradiol levels and Measurements of the Urinary Vitamin B3	Women 35 years or older	BASIS™	Completed	Not published	ClinicalTrials.gov Identifier: NCT04841499